These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29167529)

  • 1. Liver-specific deletion of RORα aggravates diet-induced nonalcoholic steatohepatitis by inducing mitochondrial dysfunction.
    Kim HJ; Han YH; Na H; Kim JY; Kim T; Kim HJ; Shin C; Lee JW; Lee MO
    Sci Rep; 2017 Nov; 7(1):16041. PubMed ID: 29167529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RORα contributes to the maintenance of genome ploidy in the liver of mice with diet-induced nonalcoholic steatohepatitis.
    Kim JY; Yang IS; Kim HJ; Yoon JY; Han YH; Seong JK; Lee MO
    Am J Physiol Endocrinol Metab; 2022 Feb; 322(2):E118-E131. PubMed ID: 34894722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RORα Induces KLF4-Mediated M2 Polarization in the Liver Macrophages that Protect against Nonalcoholic Steatohepatitis.
    Han YH; Kim HJ; Na H; Nam MW; Kim JY; Kim JS; Koo SH; Lee MO
    Cell Rep; 2017 Jul; 20(1):124-135. PubMed ID: 28683306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A maresin 1/RORα/12-lipoxygenase autoregulatory circuit prevents inflammation and progression of nonalcoholic steatohepatitis.
    Han YH; Shin KO; Kim JY; Khadka DB; Kim HJ; Lee YM; Cho WJ; Cha JY; Lee BJ; Lee MO
    J Clin Invest; 2019 Mar; 129(4):1684-1698. PubMed ID: 30855276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RORα Enhances Lysosomal Acidification and Autophagic Flux in the Hepatocytes.
    Kim HJ; Han YH; Kim JY; Lee MO
    Hepatol Commun; 2021 Dec; 5(12):2121-2138. PubMed ID: 34558854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-Inflammatory CXCR3 Impairs Mitochondrial Function in Experimental Non-Alcoholic Steatohepatitis.
    Du J; Zhang X; Han J; Man K; Zhang Y; Chu ES; Nan Y; Yu J
    Theranostics; 2017; 7(17):4192-4203. PubMed ID: 29158819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of the nuclear receptor RORα in macrophages does not modify the development of obesity, insulin resistance and NASH.
    L'homme L; Sermikli BP; Molendi-Coste O; Fleury S; Quemener S; Le Maître M; Joseph ML; Pineau L; Duhem C; Gross B; Vallez E; Tailleux A; Staels B; Dombrowicz D
    Sci Rep; 2020 Dec; 10(1):21095. PubMed ID: 33273527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RORα decreases oxidative stress through the induction of SOD2 and GPx1 expression and thereby protects against nonalcoholic steatohepatitis in mice.
    Han YH; Kim HJ; Kim EJ; Kim KS; Hong S; Park HG; Lee MO
    Antioxid Redox Signal; 2014 Nov; 21(15):2083-94. PubMed ID: 24597775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. eNOS deletion impairs mitochondrial quality control and exacerbates Western diet-induced NASH.
    Sheldon RD; Meers GM; Morris EM; Linden MA; Cunningham RP; Ibdah JA; Thyfault JP; Laughlin MH; Rector RS
    Am J Physiol Endocrinol Metab; 2019 Oct; 317(4):E605-E616. PubMed ID: 31361543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered cellular redox status, sirtuin abundance and clock gene expression in a mouse model of developmentally primed NASH.
    Bruce KD; Szczepankiewicz D; Sihota KK; Ravindraanandan M; Thomas H; Lillycrop KA; Burdge GC; Hanson MA; Byrne CD; Cagampang FR
    Biochim Biophys Acta; 2016 Jul; 1861(7):584-93. PubMed ID: 27040510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver-specific RORα deletion does not affect the metabolic susceptibility to western style diet feeding.
    Molinaro A; Caesar R; L'homme L; Koh A; Ståhlman M; Staels B; Bäckhed F
    Mol Metab; 2019 May; 23():82-87. PubMed ID: 30904385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heme oxygenase-1 prevents non-alcoholic steatohepatitis through modulating mitochondrial quality control.
    Li D; Yuan X; Dong S; Al-Dhamin Z; Du J; Fu N; Nan Y
    Acta Physiol (Oxf); 2023 Mar; 237(3):e13918. PubMed ID: 36602456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction.
    Boland ML; Oldham S; Boland BB; Will S; Lapointe JM; Guionaud S; Rhodes CJ; Trevaskis JL
    World J Gastroenterol; 2018 Apr; 24(16):1748-1765. PubMed ID: 29713129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease in mice with hepatocyte-specific deletion of mitochondrial fission factor.
    Takeichi Y; Miyazawa T; Sakamoto S; Hanada Y; Wang L; Gotoh K; Uchida K; Katsuhara S; Sakamoto R; Ishihara T; Masuda K; Ishihara N; Nomura M; Ogawa Y
    Diabetologia; 2021 Sep; 64(9):2092-2107. PubMed ID: 34052855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver cyclophilin D deficiency inhibits the progression of early NASH by ameliorating steatosis and inflammation.
    Li X; Yang M; Sun H; Ferdous MRU; Gao L; Zhao J; Song Y
    Biochem Biophys Res Commun; 2022 Feb; 594():168-176. PubMed ID: 35085894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis.
    Verbeek J; Lannoo M; Pirinen E; Ryu D; Spincemaille P; Vander Elst I; Windmolders P; Thevissen K; Cammue BP; van Pelt J; Fransis S; Van Eyken P; Ceuterick-De Groote C; Van Veldhoven PP; Bedossa P; Nevens F; Auwerx J; Cassiman D
    Gut; 2015 Apr; 64(4):673-83. PubMed ID: 24917551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RORα autoregulates its transcription via MLL4-associated enhancer remodeling in the liver.
    Han YH; Kim HJ; Choi H; Lee S; Lee MO
    Life Sci; 2020 Sep; 256():118007. PubMed ID: 32598934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IDH2 protects against nonalcoholic steatohepatitis by alleviating dyslipidemia regulated by oxidative stress.
    Gong F; Gao L; Ding T
    Biochem Biophys Res Commun; 2019 Jun; 514(3):593-600. PubMed ID: 31064654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Mitochondria-Located circRNA SCAR Alleviates NASH via Reducing mROS Output.
    Zhao Q; Liu J; Deng H; Ma R; Liao JY; Liang H; Hu J; Li J; Guo Z; Cai J; Xu X; Gao Z; Su S
    Cell; 2020 Oct; 183(1):76-93.e22. PubMed ID: 32931733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel HSF1 activator ameliorates non-alcoholic steatohepatitis by stimulating mitochondrial adaptive oxidation.
    Rao Y; Li C; Hu YT; Xu YH; Song BB; Guo SY; Jiang Z; Zhao DD; Chen SB; Tan JH; Huang SL; Li QJ; Wang XJ; Zhang YJ; Ye JM; Huang ZS
    Br J Pharmacol; 2022 Apr; 179(7):1411-1432. PubMed ID: 34783017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.